Repositório Institucional da UFMG
metadata only
CC BY-NC-ND 3.0
Mercado de medicamentos no Brasil: uma análise da descontinuação da produção no período de 2018 a 2022.
The pharmaceutical industry in Brazil is known for its limited capacity for innovation, low capitalization, and a predominant focus on the production of generic drugs. Multinational companies, on the other hand, lead the market in pharmaceutical inputs, innovative drugs, and high-value-added product
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- O impacto econômico dos acidentes de trabalho na indústria da construção brasileira entre 2002 e 2006#947446
- Pharmaceutical Public-Private Partnerships in the United States and Europe: Moving from the Bench to the Bedside#271038
- Pharmaceutical access in Brazil: challenges and opportunities#271020
- The pharmaceutical industry's multifaceted role in neglected tropical disease control: from market failure to global health innovation.#182582
- Patent Strategies and Competition Law in the Pharmaceutical Sector: Implications for Access to Medicines#271000
Record · ID 1427992
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive